Snowball logo
logo
6005

Jiangsu Lianhuan Pharmaceutical Co Ltd

600513 • SHG
14,85 ¥+0,08 ¥  (0,54%)
Оценка
EPS
-0,16
Бета
-0,231
Рост
Выручка, YoY
21,11%
Чистый доход, YoY
-82,23%
FCF, YoY
57,41%
Другое
Размер лота
1 шт.
О компании
Тикер
600513
ISIN
CNE000001DP6
Страна
КНР (Китайская Народная Республика)
Сектор (GICS)
Здравоохранение
Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, dapoxetine hydrochloride, milrinone injection, aprilite, ebastine tablets, felodipine tablets, tadalafil, and betasine besylate tablets, as well as danazol suppositories, drapavelin hydrochloride injection, and terfenadine tablets. It also provides urinary system drugs, including eprepitant tablets, terazosin tablets, and drotaverine hydrochloride injections; antihistamines comprising terfenadine, and cetirizine hydrochloride tablets; cardiovascular drugs that include felodipine, simvastatin, and amlodipine maleate tablets; steroid hormones, which consist of prazosinone sulfate sodium for injection and danazol capsules; and antibiotics, such as oxithromycin capsules. In addition, the company offers API products, such as hydrocortisone, hydrocortisone acetate, levonorgestrel, dexamethasone sodium phosphate, dexamethasone acetate, tazarotene, saxagliptin monohydrate, sacubitril valsartan sodium, adapalene, milrinone, phentolamine mesylate, terfenadine, aminomethylbenzoic acid, lumbrokinase, chloramphenicol, balofoxacin, fludrocortisone acetate, relugolix, bilastine, crisaborole, argatroban, hexyl aminolevulinate hydrochloride, finerenone, enarodustat, dotinurad, methylprednisolone succinate, hydrocortisone sodium succinate, arotinolol hydrochloride, darlotamide, adapalene, triamcinolone acetonide acetate, baloxavir marboxil, acetoacetate methylprednisolone, vericiguat, and pemafibrate. Further, it engages in the wholesale of chemical raw materials and pharmaceuticals, as well as the sale of medical equipment and electronic products. The company exports its products. Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in 1999 and is based in Yangzhou, China.

Часто задаваемые вопросы

В каком секторе работает Jiangsu Lianhuan Pharmaceutical Co Ltd (600513)?

Jiangsu Lianhuan Pharmaceutical Co Ltd относится к сектору Здравоохранение.

Какова текущая цена акций Jiangsu Lianhuan Pharmaceutical Co Ltd (600513)?

По последним данным, цена акций Jiangsu Lianhuan Pharmaceutical Co Ltd составляет 14,85 CN¥, предыдущее закрытие — 14,77 CN¥. За последнюю торговую сессию акции Jiangsu Lianhuan Pharmaceutical Co Ltd выросли на 0,08 CN¥, что соответствует росту на 0,54%.

Выплачивает ли Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) дивиденды?

Нет, Jiangsu Lianhuan Pharmaceutical Co Ltd не выплачивает дивиденды.

Какой бета-коэффициент (волатильность) у Jiangsu Lianhuan Pharmaceutical Co Ltd (600513)?

У компании Jiangsu Lianhuan Pharmaceutical Co Ltd бета -0.231, что указывает на более низкую волатильность по сравнению с рынком в целом.